Centene Corporation (NYSE: CNC) today announced its financial
results for the fourth quarter and year ended December 31, 2005.
-0- *T
----------------------------------------------------------------------
Fourth Quarter Highlights Full Year Highlights
----------------------------------
---------------------------------- -- Revenues increased 46.9% to
-- Revenues increased 50.4% to $423.2 million $1.5 billion --
Earnings from operations -- Earnings from operations increased
17.0% to $20.4 increased 22.7% to $79.2 million million -- EPS
increased 14.8% to $0.31 -- EPS increased 21.6% to $1.24 --
Operating cash flows of $29.1 -- Operating cash flows of $74.0
million million *T Additional Highlights -- Acquired US Script,
Inc., a pharmacy benefits manager. -- Membership growth of 12.8%
over the fourth quarter of 2004; organic membership growth of 7.8%
over the same prior year period. -- Days in claims payable of 45.4.
-- Authorized stock repurchase program of up to 4 million shares of
Centene's common stock. -- Announced key management appointments to
support stated goal of building a multi-line healthcare enterprise.
-- Named to The Forbes Platinum 400, a list of America's Best Big
Companies. Michael F. Neidorff, Centene's Chairman and Chief
Executive Officer, stated, "We are pleased with our 2005 results,
given some market specific challenges that we faced during the
year. The strength of our information systems, disciplined
contracting methodology and growing business diversification give
us ongoing visibility and confidence in the stability and
predictability of our business model. "During the quarter, growth
in our Kansas, Indiana and New Jersey markets was strong.
Specifically, Indiana completed the conversion of its remaining
counties to mandatory status. We are pleased that, despite intense
competition for these recipients, we achieved this significant
growth in Indiana while remaining disciplined in contracting and in
our approach to gaining membership. The primary challenge in
converting recipients into a managed care setting is educating them
on how best to access the healthcare system, which takes time and
temporarily increases our medical costs. We saw this occur in the
Indiana expansion and expect a similar impact as we roll out
Georgia later this year. We are well-positioned for growth in
Kansas and the State has plans to extend its existing Medicaid
contract through the end of 2006. "In Texas, there were a number of
factors that affected our membership results during the fourth
quarter, including the State's conversion to both a new enrollment
broker and a new eligibility system. We achieved increased
penetration in our existing service areas, while the overall market
contracted. We believe that this market condition could continue to
cause enrollment issues similar to those that were experienced in
this fourth quarter. However, we still anticipate the service area
expansion awards to be effective September 1, 2006. "Regarding
Georgia, our newest state, we anticipate that membership operations
will commence on April 1; we are fully prepared to meet that
schedule, and are working with the State to minimize further
delays. "We are pleased with our recent acquisition of US Script,
Inc., a pharmacy benefits manager, which adds another important
service component to our specialty company business and will help
us to contain and manage the most significant cost driver in
healthcare-prescription drug costs. "We are looking forward to the
opportunities in 2006, and are confident that we are well
positioned with strong operating systems, growing depth of
management and financial resources to meet them," concluded
Neidorff. The following table depicts Medicaid Managed Care
membership by state at December 31, 2005 and 2004: -0- *T 2005 2004
-------------- -------------- Indiana 193,300 150,600 Kansas
113,300 94,200 Missouri 36,000 41,200 New Jersey 56,500 52,800 Ohio
58,700 23,800 Texas 242,000 244,300 Wisconsin 172,100 165,800
-------------- -------------- TOTAL 871,900 772,700 ==============
============== 2005 2004 -------------- -------------- Medicaid
681,100 580,200 SCHIP 175,900 182,100 SSI 14,900(a) 10,400(b)
-------------- -------------- TOTAL 871,900 772,700 ==============
============== (a) 8,100 at-risk; 6,800 ASO (b) 4,600 at-risk;
5,800 ASO *T The following table depicts Specialty Services
membership (1) by state at December 31, 2005 and 2004: -0- *T 2005
2004 -------------- -------------- Arizona 94,700 - Kansas 38,800 -
-------------- -------------- TOTAL 133,500 - ==============
============== (1) Includes behavioral health contracts only. *T
Statement of Earnings Highlights -- For the fourth quarter of 2005,
revenues increased 46.9% to $423.2 million from $288.1 million in
the fourth quarter of 2004. -- For the fourth quarter of 2005, the
health benefits ratio (HBR) for Centene's Medicaid and SCHIP
populations was 82.1%, within the guided range of 81.5% to 83.5%,
which primarily reflected increased costs associated with
transitioning Indiana membership from an unmanaged setting into
Medicaid managed care. Centene's HBR for the SSI population was
105.4% during the quarter, primarily due to growth in its Wisconsin
market. One of the factors which affected the SSI HBR is a
sixty-day continuity of care requirement in Wisconsin. The
continuity of care requirement limits our ability to implement
generic drug substitution or formulary utilization, appropriately
manage inpatient utilization and monitor excessive durable medical
equipment utilization. As Centene begins to manage these specific
cost drivers, it expects the SSI HBR to fall into the target range
of 84% to 86%. For the Specialty Services segment, the HBR was
85.0%, reflecting the receipt of an anticipated positive settlement
associated with the Kansas behavioral health contract. -- The table
below depicts Centene's HBR by member category: -0- *T Three Months
Ended December 31, -------------------------------- 2005 2004
-------------- -------------- Medicaid and SCHIP 82.1% 80.2% SSI
105.4 84.7 Specialty Services 85.0 - *T -- Our Medicaid Managed
Care general and administrative (G&A) expenses as a percent of
revenues was 10.3% in the fourth quarter of 2005 compared to 11.4%
in the fourth quarter of 2004. This reduction reflected lower
compensation costs related to Centene's year-end performance
bonuses, which in part is driven by stock performance. -- Earnings
from operations increased 17.0% to $20.4 million in the fourth
quarter of 2005 from $17.4 million in the fourth quarter of 2004.
-- Net earnings were $13.9 million, or $0.31 per diluted share, for
the fourth quarter of 2005 compared to $12.0 million, or $0.27 per
diluted share, for the fourth quarter of 2004. -- For the year
ended December 31, 2005, revenues increased 50.4% to $1.5 billion
from $1.0 billion in 2004. The HBR for the Medicaid and SCHIP
populations was 81.7% in 2005 compared to 80.4% in 2004. The
increase is comprised of 0.3% of Aurora litigation settlement costs
and 0.3% for medical costs experience in the new Indiana service
areas. The remaining balance is normal variations. Earnings from
operations increased 22.7% to $79.2 million in 2005 from $64.5
million in 2004. Net earnings improved to $55.6 million, or $1.24
per diluted share, in 2005 compared to $44.3 million, or $1.02 per
diluted share, in 2004. Balance Sheet Highlights At December 31,
2005, the Company had cash and investments of $350.3 million, of
which $322.6 million was held by Centene's regulated entities.
Medical claims liabilities totaled $170.5 million, representing
45.4 days in claims payable. A reconciliation of the Company's
change in days in claims payable from the immediately preceding
quarter is presented below: -0- *T Days in claims payable,
September 30, 2005 41.4 Increase in claims inventory 4.3 Payment of
quarterly provider settlements (0.3) -------------- Days in claims
payable, December 31, 2005 45.4 ============== *T Outlook Karey L.
Witty, Centene's Chief Financial Officer, commented, "Our first
quarter 2006 revenue guidance is in the range of $444 million to
$449 million, and we anticipate net earnings of $0.17 to $0.21 per
diluted share. For full year 2006, we anticipate revenue in the
range of $2.15 billion to $2.25 billion, and net earnings per
diluted share of $1.61 to $1.78." Guidance for 2006 includes the
effect of new accounting rules requiring the expensing of stock
options. The Financial Accounting Standards Board (FASB) has issued
FASB Statement No. 123R, "Share-Based Payment," which covers a
range of share-based compensation arrangements, including stock
options. Centene began expensing stock options effective January 1,
2006, in accordance with the requirements of FASB Statement No.
123R, the effect of which is expected to reduce diluted earnings
per share by approximately $0.04 per share in the first quarter of
2006 and $0.15 per share for the full year. A review of the results
for the fourth quarter and additional details on management's
outlook for 2006 will take place during the Company's scheduled
fourth quarter earnings call. -0- *T 2006
---------------------------------------------- Q1 Year
---------------------- ---------------------- Low High Low High
---------- ---------- ---------- ---------- Revenue (in millions) $
444 $ 449 $ 2,150 $ 2,250 Earnings per share $ 0.34 $ 0.35 $ 1.72 $
1.87 Georgia implementation costs (0.11) (0.09) (a) (a) SFAS No.
123R (0.04) (0.04) (0.15) (0.15) US Script (0.02) (0.01) 0.04 0.06
---------- ---------- ---------- ---------- Adjusted earnings per
share $ 0.17 $ 0.21 $ 1.61 $ 1.78 ========== ========== ==========
========== (a) Georgia effective April 1, 2006 *T Conference Call
As previously announced, the Company will host a conference call
today, February 7, 2006, at 8:30 a.m. (Eastern Time) to review the
financial results for the quarter and year ended December 31, 2005,
and to discuss its business outlook. Michael F. Neidorff and Karey
L. Witty will host the conference call. Investors are invited to
participate in the conference call by dialing 800-273-1254 in the
U.S. and Canada, 706-679-8592 from abroad, or via a live Internet
broadcast on the Company's website at www.centene.com, under the
Investor Relations section. A replay will be available for on
demand listening shortly after the completion of the call until
11:59 p.m. (Eastern Time) on February 21, 2006 at the
aforementioned URL, or by dialing 800-642-1687 in the U.S. and
Canada, or 706-645-9291 from abroad, and entering access code
3978030. About Centene Corporation Centene Corporation provides
multi-line managed care programs and related services to
individuals receiving benefits under Medicaid, including
Supplemental Security Income (SSI), and the State Children's Health
Insurance Program (SCHIP). The Company operates health plans in
Indiana, Kansas, Missouri, New Jersey, Ohio, Texas and Wisconsin.
In addition, the Company contracts with other healthcare
organizations to provide Specialty Services including behavioral
health, disease management, nurse triage, pharmacy benefit
management and treatment compliance. Information regarding Centene
is available via the Internet at www.centene.com. The information
provided in the second, third and fourth paragraphs immediately
following the bulleted listings under "Additional Highlights," the
second bulleted listing under "Statement of Earnings Highlights,"
and the paragraphs under "Outlook" above contain forward-looking
statements that relate to future events and future financial
performance of Centene. These forward-looking statements represent
the Company's estimates as of February 7, 2006. Subsequent events
and developments may cause the Company's estimates to change. The
Company disclaims any obligation to update this forward-looking
financial information in the future. Readers are cautioned that
matters subject to forward-looking statements involve known and
unknown risks and uncertainties, including economic, regulatory,
competitive and other factors that may cause Centene's or its
industry's actual results, levels of activity, performance or
achievements to be materially different from any future results,
levels of activity, performance or achievements expressed or
implied by these forward-looking statements. Actual results may
differ from projections or estimates due to a variety of important
factors, including Centene's ability to accurately predict and
effectively manage health benefits and other operating expenses,
competition, changes in healthcare practices, changes in federal or
state laws or regulations, inflation, provider contract changes,
new technologies, reduction in provider payments by governmental
payors, major epidemics, disasters and numerous other factors
affecting the delivery and cost of healthcare. The expiration,
cancellation or suspension of Centene's Medicaid managed care
contracts by state governments would also negatively affect
Centene. In addition, the actual effect of SFAS 123R on Centene's
earnings per share may vary significantly due to changes in its
future stock-based compensation strategy, stock price volatility,
forfeitures and employee stock option exercise behavior. -0- *T
CENTENE CORPORATION AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS
(In thousands, except share data) December 31,
--------------------- 2005 2004 ---------- ---------- ASSETS
Current assets: Cash and cash equivalents $147,358 $84,105 Premium
and related receivables, net of allowances of $343 and $462,
respectively 44,108 31,475 Short-term investments, at fair value
(amortized cost $56,863 and $94,442, respectively) 56,700 94,283
Other current assets 24,439 14,429 --------- --------- Total
current assets 272,605 224,292 Long-term investments, at fair value
(amortized cost $126,039 and $117,177, respectively) 123,661
116,787 Restricted deposits, at fair value (amortized cost $22,821
and $22,295, respectively) 22,555 22,187 Property, software and
equipment, net 67,199 43,248 Goodwill 157,278 101,631 Other
intangible assets, net 17,368 14,439 Other assets 7,364 5,350
--------- --------- Total assets $668,030 $527,934 =========
========= LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities:
Medical claims liabilities $170,514 $165,980 Accounts payable and
accrued expenses 29,790 31,737 Unearned revenue 13,648 3,956
Current portion of long-term debt and notes payable 699 486
--------- --------- Total current liabilities 214,651 202,159
Long-term debt 92,448 46,973 Other liabilities 8,883 7,490
--------- --------- Total liabilities 315,982 256,622 Stockholders'
equity: Common stock, $.001 par value; authorized 100,000,000
shares; issued and outstanding 42,988,230 and 41,316,122 shares,
respectively 43 41 Additional paid-in capital 191,840 165,391
Accumulated other comprehensive income: Unrealized loss on
investments, net of tax (1,754 ) (407) Retained earnings 161,919
106,287 --------- --------- Total stockholders' equity 352,048
271,312 --------- --------- Total liabilities and stockholders'
equity $668,030 $527,934 ========= ========= CENTENE CORPORATION
AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS (In thousands,
except share data) THREE MONTHS ENDED YEAR ENDED DECEMBER 31,
DECEMBER 31, --------------------- ---------------------- 2005 2004
2005 2004 --------------------- ---------------------- (Unaudited)
Revenues: Premium $416,872 $286,117 $1,491,899 $991,673 Service
6,346 1,947 13,965 9,267 ----------- --------- -----------
---------- Total revenues 423,218 288,064 1,505,864 1,000,940
----------- --------- ----------- ---------- Expenses: Medical
costs 345,888 229,756 1,226,909 800,476 Cost of services 2,278
1,916 5,851 8,065 General and administrative expenses 54,639 38,948
193,913 127,863 ----------- --------- ----------- ---------- Total
operating expenses 402,805 270,620 1,426,673 936,404 -----------
--------- ----------- ---------- Earnings from operations 20,413
17,444 79,191 64,536 Other income (expense): Investment and other
income 3,194 1,902 10,655 6,431 Interest expense (1,604) (363)
(3,990) (680) ----------- --------- ----------- ---------- Earnings
before income taxes 22,003 18,983 85,856 70,287 Income tax expense
8,137 6,973 30,224 25,975 ----------- --------- -----------
---------- Net earnings $13,866 $12,010 $55,632 $44,312 ===========
========= =========== ========== Earnings per share: Basic earnings
per common share $0.32 $0.29 $1.31 $1.09 Diluted earnings per
common share $0.31 $0.27 $1.24 $1.02 Weighted average number of
shares outstanding: Basic 42,885,900 41,199,463 42,312,522
40,820,909 Diluted 44,812,159 44,309,636 45,027,633 43,616,445
CENTENE CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF
CASH FLOWS (In thousands) Year Ended December 31,
---------------------- 2005 2004 ---------- ---------- Cash flows
from operating activities: Net earnings $55,632 $44,312 Adjustments
to reconcile net earnings to net cash provided by operating
activities-- Depreciation and amortization 13,069 10,014 Tax
benefits related to stock options 6,469 3,316 Stock compensation
expense 4,974 650 Loss (gain) on sale of investments 70 (138) Loss
on disposal of property and equipment 454 -- Deferred income taxes
1,786 (1,638) Changes in assets and liabilities-- Premium and
related receivables (10,305) (425) Other current assets (6,177)
(786) Other assets (525) (728) Medical claims liabilities 4,534
34,501 Unearned revenue 8,182 283 Accounts payable and accrued
expenses (4,215) 9,951 Other operating activities 100 93 ---------
--------- Net cash provided by operating activities 74,048 99,405
--------- --------- Cash flows from investing activities: Purchase
of property, software and equipment (26,909) (25,009) Purchase of
investments (150,444) (254,358) Sales and maturities of investments
176,387 243,623 Acquisitions, net of cash acquired (55,485)
(86,739) --------- --------- Net cash used in investing activities
(56,451) (122,483) --------- --------- Cash flows from financing
activities: Proceeds from exercise of stock options 5,621 4,066
Proceeds from borrowings 45,000 45,860 Reduction of long-term debt
and notes payable (4,552) (6,596) Other financing activities (413)
(493) --------- --------- Net cash provided by financing activities
45,656 42,837 --------- --------- Net increase in cash and cash
equivalents 63,253 19,759 --------- --------- Cash and cash
equivalents, beginning of period 84,105 64,346 --------- ---------
Cash and cash equivalents, end of period $147,358 $84,105 =========
========= Interest paid $3,291 $494 Income taxes paid $31,287
$20,518 Supplemental schedule of non-cash investing and financing
activities: Common stock issued for acquisitions $8,991 $--
Property acquired under capital leases $5,026 $-- CENTENE
CORPORATION SUPPLEMENTAL FINANCIAL DATA Q4 Q3 Q2 Q1 2005 2005 2005
2005 --------- --------- --------- --------- MEMBERSHIP Medicaid
Managed Care: Indiana 193,300 176,300 152,800 149,900 Kansas
113,300 107,600 103,000 94,900 Missouri 36,000 37,300 39,900 41,300
New Jersey 56,500 50,900 52,900 52,700 Ohio 58,700 58,100 59,600
23,900 Texas 242,000 243,600 243,800 243,700 Wisconsin 172,100
173,900 173,400 170,900 --------- --------- --------- ---------
TOTAL 871,900 847,700 825,400 777,300 ========= ========= =========
========= Medicaid 681,100 657,500 637,300 588,100 SCHIP 175,900
176,900 176,200 178,500 SSI 14,900 13,300 11,900 10,700 ---------
--------- --------- --------- TOTAL 871,900 847,700 825,400 777,300
========= ========= ========= ========= Specialty Services: Arizona
94,700 94,300 - - Kansas 38,800 37,500 37,100 35,400 ---------
--------- --------- --------- TOTAL 133,500 131,800 37,100 35,400
========= ========= ========= ========= REVENUE PER MEMBER(a)
$152.48 $147.73 $143.41 $142.15 CLAIMS(a) Period-end inventory
255,000 206,900 195,500 227,700 Average inventory 153,500 148,300
170,300 191,900 Period-end inventory per member 0.29 0.24 0.24 0.29
(a) Revenue per member and claims information are presented for the
Medicaid Managed Care segment. DAYS IN CLAIMS PAYABLE(b) 45.4 41.4
49.5 59.7 (b) Days in Claims Payable is a calculation of Medical
Claims Liabilities at the end of the period divided by average
claims expense per calendar day for such period. CASH AND
INVESTMENTS (in millions) Regulated $322.6 $305.1 $260.5 $295.0
Unregulated 27.7 27.7 27.4 42.1 TOTAL $350.3 $332.8 $287.9 $337.1
========= ========= ========= ========= ANNUALIZED RETURN ON EQUITY
(c) 16.2% 14.9% 20.0% 20.5% (c) Annualized Return on Equity is
calculated as follows: (net income for quarter x 4) divided by
((beginning of period equity + end of period equity) divided by 2).
HEALTH BENEFITS RATIO BY CATEGORY: Three Months Twelve Months Ended
Dec. 31, Ended Dec. 31, --------------- ----------------- 2005 2004
2005 2004 --------------- ----------------- Medicaid and SCHIP
82.1% 80.2% 81.7% 80.4% SSI 105.4 84.7 97.5 93.8 Specialty Services
85.0 - 88.1 - GENERAL AND ADMINISTRATIVE EXPENSE RATIO BY BUSINESS
SEGMENT: Three Months Twelve Months Ended Dec. 31, Ended Dec. 31,
------------------ --------------- 2005 2004 2005 2004
------------------ --------------- Medicaid Managed Care 10.3%
11.4% 10.5% 10.7% Specialty Services 30.3 53.7 35.4 52.3 MEDICAL
CLAIMS LIABILITIES (In thousands) Changes in medical claims
liabilities during 2005 are summarized as follows: Balance, January
1, 2005 $165,980 Acquisitions -- Incurred related to: Current
period 1,244,600 Prior period (17,691) ----------- Total incurred
1,226,909 ----------- Paid related to: Current period 1,075,204
Prior period 147,171 ----------- Total paid 1,222,375 -----------
Balance, December 31, 2005 $170,514 =========== Centene's claims
reserving process utilizes a consistent actuarial methodology to
estimate Centene's ultimate liability. Any reduction in the
"Incurred related to: Prior period" claims may be offset as Centene
actuarially determines "Incurred related to: Current period." As
such, only in the absence of a consistent reserving methodology
would favorable development of prior period claims liability
estimates reduce medical costs. Centene believes it has
consistently applied its claims reserving methodology in each of
the periods presented. *T
Centene (NYSE:CNC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Centene (NYSE:CNC)
Historical Stock Chart
From Jul 2023 to Jul 2024